Katy Spink, Ph.D.

Katharine (Katy) Spink Ph.D. combines nearly two decades of C&GT operating experience with strategic vision and a well-deserved reputation as an incisive analytical mind. Cross-functional leadership experience across the technical foundations of C&GT makes Katy effective in providing expert guidance in integration and overlap of all industry needs. Dr. Spink’s pre-Dark Horse experience included management consulting with McKinsey & Company as well as executive roles in the field of Cell & Gene Therapy.